In the context of cancer, IL18 enables the recruitment of tumor-infiltrating lymphocytes,6,7 natural killer (NK) cells,8 dendritic cells (DCs),8 and M1-polarized macrophages4 while reducing regulatory T cells and M2-polarized macrophages.4 This evidence concerns the gene IL18 and neoplasm.